Published in Ophthalmology on August 01, 2003
Anterior Segment Scleral Fluorescein Angiography in the Evaluation of Ciliary Body Neoplasm: Two Case Reports. Case Rep Ophthalmol (2016) 0.79
[Diagnosis and treatment of episcleritis and scleritis]. Ophthalmologe (2016) 0.78
Swept Source Optical Coherence Tomography Angiography for Contact Lens-Related Corneal Vascularization. J Ophthalmol (2016) 0.75
Serial optical coherence tomography angiography for corneal vascularization. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res (2009) 1.94
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol (2011) 1.78
Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm. Cancer Res (2010) 1.59
The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med (2007) 1.50
Fundus autofluorescence imaging of retinal dystrophies. Vision Res (2008) 1.48
Detection of M2-macrophages in uveal melanoma and relation with survival. Invest Ophthalmol Vis Sci (2011) 1.37
The spectrum of retinal dystrophies caused by mutations in the peripherin/RDS gene. Prog Retin Eye Res (2008) 1.37
Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol (2006) 1.33
Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. Invest Ophthalmol Vis Sci (2002) 1.33
Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.18
Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci (2010) 1.18
In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages. J Immunol (2010) 1.15
The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol (2009) 1.13
Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 1.08
Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. Ophthalmology (2013) 1.06
Authenticating cell lines in ophthalmic research laboratories. Invest Ophthalmol Vis Sci (2008) 1.03
Subclinical changes in the juvenile crystalline macular dystrophy in Sjögren-Larsson syndrome detected by optical coherence tomography. Ophthalmology (2007) 1.03
A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma. J Immunol (2007) 1.01
Association of whirlin with Cav1.3 (alpha1D) channels in photoreceptors, defining a novel member of the usher protein network. Invest Ophthalmol Vis Sci (2009) 1.01
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One (2012) 1.01
Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degeneration. Ophthalmology (2012) 1.01
Regulation of VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci (2009) 1.00
CLRN1 mutations cause nonsyndromic retinitis pigmentosa. Ophthalmology (2011) 0.98
Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer (2003) 0.98
Role of TRAIL and IFN-gamma in CD4+ T cell-dependent tumor rejection in the anterior chamber of the eye. J Immunol (2003) 0.96
Eccentric gaze direction in patients with central field loss. Optom Vis Sci (2011) 0.96
Epigenetic inactivation of RASSF1a in uveal melanoma. Invest Ophthalmol Vis Sci (2007) 0.95
Heat shock protein expression in the eye and in uveal melanoma. Invest Ophthalmol Vis Sci (2003) 0.95
Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Pathol Lab Med (2011) 0.95
Macrophages are vital in spontaneous intraocular tumor eradication. Invest Ophthalmol Vis Sci (2006) 0.94
The effect of latanoprost on intraocular pressure during 2 years of treatment. Surv Ophthalmol (2002) 0.91
Clinical and molecular genetic analysis of best vitelliform macular dystrophy. Retina (2009) 0.91
Epigenetic silencing of MHC2TA transcription in cancer. Biochem Pharmacol (2006) 0.91
Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration. Invest Ophthalmol Vis Sci (2010) 0.91
Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Invest Ophthalmol Vis Sci (2005) 0.89
Correspondence. Retina (2015) 0.88
A pilot study on slit lamp-adapted optical coherence tomography imaging of trabeculectomy filtering blebs. Graefes Arch Clin Exp Ophthalmol (2006) 0.88
Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes. J Immunol (2008) 0.88
Uveal melanoma: the inflammatory microenvironment. J Innate Immun (2012) 0.87
The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy. Acta Ophthalmol (2014) 0.87
Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.87
Melanoma vaccines: The problems of local immunosuppression. Hum Immunol (2009) 0.86
Prognostic value of S-100-beta serum concentration in patients with uveal melanoma. Arch Ophthalmol (2003) 0.86
A homozygous frameshift mutation in LRAT causes retinitis punctata albescens. Ophthalmology (2012) 0.86
Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanoma. J Immunol (2012) 0.85
Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression. Invest Ophthalmol Vis Sci (2006) 0.85
Intraocular tumor antigen drains specifically to submandibular lymph nodes, resulting in an abortive cytotoxic T cell reaction. J Immunol (2004) 0.84
Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma. Radiother Oncol (2010) 0.84
Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res (2004) 0.84
A fish scale-derived collagen matrix as artificial cornea in rats: properties and potential. Invest Ophthalmol Vis Sci (2013) 0.84
Uveal and cutaneous melanoma: shared expression characteristics of melanoma-associated antigens. Invest Ophthalmol Vis Sci (2005) 0.84
Mitochondrial retinal dystrophy associated with the m.3243A>G mutation. Ophthalmology (2013) 0.84
Expression of CD133 and other putative stem cell markers in uveal melanoma. Melanoma Res (2011) 0.83
Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma. Invest Ophthalmol Vis Sci (2008) 0.83
Blindness and low vision in The Netherlands from 2000 to 2020-modeling as a tool for focused intervention. Ophthalmic Epidemiol (2009) 0.83
Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. Melanoma Res (2007) 0.83
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Invest Ophthalmol Vis Sci (2009) 0.82
Bevacizumab and intraocular tumors: an intriguing paradox. Mol Vis (2012) 0.82
Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy. Diabetologia (2014) 0.82
Maintenance of immune tolerance depends on normal tissue homeostasis. J Immunol (2005) 0.82
Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype. Invest Ophthalmol Vis Sci (2010) 0.81
Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells. Cancer Immunol Immunother (2006) 0.81
Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.81
Anterior segment imaging for iris melanocytic tumors. Eur J Ophthalmol (2011) 0.81
Anti-angiogenic therapy in uveal melanoma. Dev Ophthalmol (2011) 0.81
Presence and maturity of dendritic cells in melanoma lymph node metastases. J Pathol (2005) 0.81
High levels of Hdmx promote cell growth in a subset of uveal melanomas. Am J Cancer Res (2012) 0.80
Fuchs' adenoma of the choroid simulating a choroidal hemangioma. Case Rep Ophthalmol (2012) 0.80
Genetics of primary intraocular tumors. Ocul Immunol Inflamm (2012) 0.80
ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion. Pigment Cell Melanoma Res (2014) 0.80
Analysis of inflammatory cells in uveal melanoma after prior irradiation. Invest Ophthalmol Vis Sci (2013) 0.79
In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells. Invest Ophthalmol Vis Sci (2005) 0.78
The biology of micrometastases from uveal melanoma. J Clin Pathol (2011) 0.78
Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth. Mol Vis (2008) 0.78
Do shapes and dimensions of scleral flap and sclerostomy influence aqueous outflow in trabeculectomy? A finite element simulation approach. Br J Ophthalmol (2011) 0.78
Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab. Acta Ophthalmol (2013) 0.78
Reflex and steady state tears in patients with latent stromal herpetic keratitis. Invest Ophthalmol Vis Sci (2002) 0.78
HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis. Invest Ophthalmol Vis Sci (2006) 0.77
The effect of ultraviolet radiation on choroidal melanocytes and melanoma cell lines: cell survival and matrix metalloproteinase production. Graefes Arch Clin Exp Ophthalmol (2006) 0.77
Presence and phenotype of dendritic cells in uveal melanoma. Br J Ophthalmol (2007) 0.77
A comparison of HLA genotype with inflammation in uveal melanoma. Invest Ophthalmol Vis Sci (2012) 0.77
The Immunology of Glaucoma. Asia Pac J Ophthalmol (Phila) (2015) 0.76
Transscleral thermotherapy with laser-induced and conductive heating in hamster Greene melanoma. Melanoma Res (2004) 0.76
Pancorneal contact lens with a toric edge: a new concept in keratoconus. Eur J Ophthalmol (2011) 0.76
Angiogenesis in uveal melanoma. Ophthalmic Res (2006) 0.75
Changes in immunological markers and influx of macrophages following trans-scleral thermotherapy of uveal melanoma. Acta Ophthalmol (2011) 0.75
Activation of tonsil dendritic cells with immuno-adjuvants. BMC Immunol (2008) 0.75
FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY. Retina (2017) 0.75
Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply. Arch Ophthalmol (2012) 0.75
Complication of hydrogel explants. Ophthalmology (2006) 0.75
Ruthenium plaque radiation therapy for iris and iridociliary melanomas. Acta Ophthalmol (2010) 0.75
Angiogenesis and vascular endothelial growth factors in intraocular tumors. Dev Ophthalmol (2010) 0.75
Corneal endothelial cell density after ruthenium plaque radiation therapy for iris melanoma patients. Acta Ophthalmol (2012) 0.75
Introducing Anneke I. den Hollander, the Recipient of the 2015 Cogan Award. Invest Ophthalmol Vis Sci (2016) 0.75
Three Generations of Eminent American Chinese: Lives Intertwined With History. Asia Pac J Ophthalmol (Phila) (2015) 0.75
Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey. Invest Ophthalmol Vis Sci (2009) 0.75